Evidence map›Paper›PMID 41767249›Full record

ArticleO&G open2026

Navigating Drug Shortages in Obstetric Care.

Gillian Piltch, David Rochelson, Burton Rochelson

Abstract read
In one paragraph

Article in O&G open, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Gillian PiltchNorthwell, New Hyde Park, New York; Department of Obstetrics and Gynecology, North Shore University Hospital, Manhasset, New York; Zucker School of Medicine at Hofstra/Northwell, Hempstead, New York; and Garwin Gerstein & Fisher LLP, New York, New York.
David RochelsonNorthwell, New Hyde Park, New York; Department of Obstetrics and Gynecology, North Shore University Hospital, Manhasset, New York; Zucker School of Medicine at Hofstra/Northwell, Hempstead, New York; and Garwin Gerstein & Fisher LLP, New York, New York.
Burton RochelsonNorthwell, New Hyde Park, New York; Department of Obstetrics and Gynecology, North Shore University Hospital, Manhasset, New York; Zucker School of Medicine at Hofstra/Northwell, Hempstead, New York; and Garwin Gerstein & Fisher LLP, New York, New York.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The number of long-duration drug shortages in the United States is increasing annually. These shortages may pose significant risks to patients by compromising or delaying care. They also pose challenges to health care systems by creating operational and financial strain. To minimize the effect on patient care, health care professionals and systems need to establish mechanisms to prepare in advance for drug shortages. In this clinical perspective, we explore the definition of drug shortage, causes of drug shortage, prediction of drug shortage, and potential responses to drug shortage. We additionally review the causes and responses to shortages of five drugs specific to obstetric care. In this era of frequent and unanticipated drug shortages, it is crucial to build the necessary teams and systems to respond to the next drug shortage to protect the health and safety of pregnant people.

Identifiers

PMID41767249
PMCPMC12947995

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.